Coffee in Health and Disease Prevention

2nd Edition - December 1, 2024
Editors: Victor R Preedy, Vinood Patel
Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 1 3 8 6 8 - 3
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 1 3 8 6 9 - 0

Coffee in Health and Disease Prevention presents a comprehensive look at the compounds in coffee, their benefits (or toxicity risks), and explores coffee as it relates to specific… Read more

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Coffee in Health and Disease Prevention presents a comprehensive look at the compounds in coffee, their benefits (or toxicity risks), and explores coffee as it relates to specific health conditions. Embracing a holistic approach, this book covers the coffee plant, the major varieties of coffee, and its nutritional and compositional properties. Coffee’s impact on human health, disease risk and prevention comprise the majority of the text. Diseases covered including Alzheimer’s, anxiety and depression, asthma cancer, diabetes, epilepsy, and more. The book also covers coffee’s impact on organs and organ systems, including the cardiovascular system, the immune system, the gut microbiome, and the muscular system.

Coffee in Health and Disease Prevention is the only book on the market that covers all varieties of coffee in one volume and their potential benefits and risks to human health. This is an essential reference for researchers in nutrition, dietetics, food science, biochemistry, and public health.

Section 1: Coffee, Coffee Drinking and Varieties

1. The coffee plant

2. Genotypes and chemical quality traits of coffee

3. Metabolomics as applied to analysis of coffee plants

4. Coffea arabica (Arabica)

5. Coffea canephora (Robusta)

6. Green coffee

7. Turkish Coffee

8. The genetics of the coffee plant

9. Coffee usage and cardiovascular effects and risk factors

10. Coffee drinking and metabolic syndrome

11. Genetic differences in coffee intakes

Section 2: Production and Processing

12. Single-serve capsule brews of coffee

13. Waste management of coffee residues

Section 3: Compositional and Nutritional Aspects

14. Coffee and its compounds: perceived bitterness intensities

15. The influence of coffee consumption and body composition

16. Effects of coffee in obesity: arterial stiffness

17. The contributing of coffee to total dietary caffeine intake

18. Espresso coffee and impact on blood cholesterol

19. Coffee composition: Ent-kaurane-type diterpene diastereomers

20. 2-phenylphenol in roasted coffee

21. COVID19 lockdown and coffee-derived caffeine intake

22. Serum biomarkers of coffee consumption

Section 4: General Aspects Of The Effects Of Coffee

23. Overview of health effects of coffee

24. Coffee and cardiovascular risk: a narrative

25. Coffee and effects on blood pressure

26. Plasma lipids, lipid metabolism and coffee

27. Coffee consumption and non-alcoholic fatty liver disease; a narrative

28. Coffee and its metabolites in relation to lung function

29. Coffee and diabetes

30. Coffee intake and asthma

31. Green coffee and the immune system

32. Coffee and effects on platelets

33. Coffee and the gut microbiome

34. Coffee intake and muscular performance

35. Coffee and exercise on blood biochemistry

36. Favourable effect of coffee on metabolic disease risk

37. Coffee components and genomics in relation to cancer

38. Metabolomic signatures of long-term coffee consumption

39. Health effects of caffeinated vs. decaffeinated coffee

40. Human genetics and coffee: Functional single-nucleotide polymorphism and response to coffee consumption

Section 5: Focused Areas, Specific Coffee Components and Effects on Tissue and Organ Systems

41. Cafestol in coffee and cellular effects

42. Caffeic acid and use in cancer pathways

43. Caffeic acid in coffee and neurological effects

44. Caffeine and coffee craving

45. Caffeine and mental health symptoms

46. Caffeine usage in Alzheimer's disease: a new narrative

47. Caffeoylquinic acid and effects on macrophages

48. Caffeoylquinic acid in coffee types and their effects

49. Chlorogenic acid and cellular energy metabolism

50. Chlorogenic acid and effects on blood pressure

51. Chlorogenic acid and usage in diabetic and prediabetic states

52. Kahweol and hepatotoxicity protection

53. Kahweol from coffee and peripheral antinociception

54. Trigonelline as a bioactive alkaloid in coffee: preventing kidney stones

55. Trigonelline in coffee and its effects

Section 6: Behavior and Brain

56. Espresso coffee and breakfast: impact on mood and cognition

57. Seizures in epilepsy and coffee consumption

58. Linking coffee, olfaction and use of grounds for assessing cognitive function

59. Blood-brain barrier and caffeine

60. Coffee consumption: links with anxiety and depression

61. Coffee and intake and dementia

Section 7: Adverse Effects of Coffee and Coffee-Related Products

62. Acrylamide in coffee

63. Toxic metals in coffee

64. Coffee and adverse birth outcomes

65. Coffee consumption in relation to sudden cardiac death

66. Adverse cardiovascular effects of coffee: tachycardia and beyond

Section 8: Comparison of Coffee and Tea in Health and Disease

67. Comparing coffee and tea with reference to multiple sclerosis

68. Comparing coffee and tea with reference to DNA methylation

69. Comparing coffee and tea with reference to clonidine-induced hypothermia

70. Comparing coffee and tea with reference to prostate cancer

71. Coffee and tea consumption and pregnancy

72. Comparing coffee and tea with reference to breast cancer

Section 9: Resources and Selective Methods

73. Methods for determining either Arabica and Robusta coffee

74. Isolation of diterpenes in coffee

75. NMR methods for profiling coffee

76. Methods for in silico studies on coffee and its extracts

77. Coffee and accelerator-based methods for its profiling

78. Genetic methods to evaluate evidence for causal effect of coffee on health

79. Resources

Victor R Preedy

Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

Affiliations and expertise

Professor, Department of Clinical Biochemistry, King’s College Hospital, London, UK; Emeritus Professor, Faculty of Life Sciences and Medicine, King’s College London, UK Visiting Professor, University of Hull, UK

Vinood Patel

Vinood B. Patel, BSc, PhD, FRSC, is currently Professor in Clinical Biochemistry at the University of Westminster. In 2014 Dr Patel was elected as a Fellow to The Royal Society of Chemistry. Dr Patel graduated from the University of Portsmouth with a degree in Pharmacology and completed his PhD in protein metabolism from King’s College London in 1997. His postdoctoral work was carried out at Wake Forest University Baptist Medical School, NC, USA studying structural-functional alterations to mitochondrial ribosomes, where he developed novel techniques to characterize their biophysical properties. Research is being undertaken to study the role of nutrients, antioxidants, phytochemicals, iron, alcohol and fatty acids in the pathophysiology of liver disease. Other areas of interest are identifying new biomarkers that can be used for the diagnosis and prognosis of disease and understanding mitochondrial oxidative stress in neurological disorders and iron dysregulation in diabetes. Dr Patel is a nationally and internationally recognized researcher and has several edited biomedical books related to the use or investigation of active agents or components. These books include The Handbook of Nutrition, Diet, and Epigenetics, Branched Chain Amino Acids in Clinical Nutrition, Cancer: Oxidative Stress and Dietary Antioxidants, Toxicology: Oxidative Stress and Dietary Antioxidants, Molecular Nutrition: Vitamins, The Neuroscience of Pain, Cognitive Behavioural Therapy. He is Editor of the ten-volume series Biomarkers in Disease: Methods, Discoveries and Applications.

Affiliations and expertise

Reader, Clinical Biochemistry, University of Westminster, London, UK